Rosetta Genomics (ROSG) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. QQQ
8. LDOS
9. HUM
10. KTOS

Go back to Rosetta Genomics (ROSG) Tops Q2 EPS by 2c

Rosetta Genomics Reports 2016 Second Quarter Financial Results

September 26, 2016 4:05 PM EDT

RosettaGX Reveal for the Diagnosis of Indeterminate Thyroid FNA Expected to Drive Significant Revenue Growth over the Next Several Years

Conference call begins today at 4:30 p.m. Eastern time

PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)-- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, reports financial results for the three and six months ended June 30, 2016.

Recent developments include:

Gross billings for RosettaGX Reveal (Reveal), the Companys first-of-its-kind microRNA classifier for indeterminate thyroid nodules, are tracking to be... More